The New U.S. Administration's Impact on Healthcare and Life Sciences

Healthcare attorney Brian Platton will participate in a Simmons + Simmons webinar exploring how the Trump Administration's policies and priorities will affect the global healthcare and life sciences sector. Notable changes initiated since President Donald Trump was elected include the nomination of Robert F. Kennedy Jr. to lead the U.S. Department of Health and Human Services (HHS), U.S. withdrawal from the World Health Organization (WHO), sweeping staff reductions across the federal government, including the U.S. Food and Drug Administration (FDA), and proposed tariffs on pharmaceutical products from China and Europe. These developments carry implications that extend beyond the United States' borders, affecting businesses and policymakers across the world. During this webinar, Mr. Platton will break down key healthcare policies and updates from Washington, D.C., and how they affect international stakeholders, including analysis of their implications for mergers and acquisitions (M&A) activity and multinational supply chains.